Jack W. Schuler Living Trust
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 31, 2021
Yield10 Bioscience
|
Post-IPO Equity | $12.70M | Biotechnology | Yes |
Nov 5, 2014
Biolase
|
Post-IPO Equity | $35M | 3D Printing | — |
Jun 6, 2014
Transition Therapeutics
|
Post-IPO Equity | $30.80M | Biopharma | — |
May 5, 2014
Accelerate Diagnostics
|
Post-IPO Equity | $45M | Consulting | — |
Jack W. Schuler Living Trust has had 4 exits. Jack W. Schuler Living Trust most notable exits include Accelerate Diagnostics , Transition Therapeutics
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Sep 3, 2013 | Accelerate Diagnostics | IPO | Consulting | Detail |
Aug 31, 2007 | Transition Therapeutics | M&A | Biopharma | Detail |
Nov 17, 2006 | Yield10 Bioscience | IPO | Biotechnology | Detail |
Jun 10, 2003 | Biolase | IPO | 3D Printing | Detail |